HeartFlow (HTFL) CMO reports large new equity awards and holdings
Rhea-AI Filing Summary
HeartFlow, Inc.'s Chief Medical Officer, Campbell Rogers, reported new equity awards and related share activity. On February 6, 2026, he received a stock option covering 94,488 shares of common stock with a $27.74 exercise price, vesting monthly over four years starting from the vesting commencement date.
On the same date, he was granted 54,073 restricted stock units, which vest in 16 equal quarterly installments beginning February 6, 2026, subject to continued service. The filing also shows 515 shares of common stock withheld at $27.74 per share to cover tax obligations upon RSU vesting, and reports additional indirect common stock holdings through several trusts.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 94,488 | $0.00 | -- |
| Tax Withholding | Common Stock | 515 | $27.74 | $14K |
| Grant/Award | Common Stock | 54,073 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported. Represents restricted stock units ("RSUs"), with a vesting commencement date of February 6, 2026 (the "Vesting Commencement Date"). 1/16th of the RSUs vest on each quarterly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date. The option vests 1/48 on each monthly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date.
FAQ
What insider transactions did HeartFlow (HTFL) report for its Chief Medical Officer?
The Chief Medical Officer reported new equity awards and tax-related share withholding. He received 94,488 stock options and 54,073 restricted stock units, plus 515 shares were withheld at $27.74 each to cover income tax obligations tied to previously reported RSU vesting.
How do the new stock options for HeartFlow (HTFL) CMO vest?
The stock option for 94,488 shares vests in 1/48 increments each month after the February 6, 2026 vesting commencement date. Continued service is required through each monthly vesting date for those installment portions to become exercisable.
What is the vesting schedule for the 54,073 RSUs reported by HeartFlow (HTFL)?
The 54,073 RSUs vest over four years starting February 6, 2026. One-sixteenth of the RSUs vest on each quarterly anniversary of that date, conditioned on the executive’s continued service through each applicable quarterly vesting date.
What indirect HeartFlow (HTFL) holdings are shown for the CMO?
The filing lists additional indirect common stock holdings through several trusts. These include shares held by the Campbell Rogers 2019 Irrevocable Trust, the CR Asset Protection Trust of 2023, a spouse’s trust, and The Campbell Rogers Revocable Trust, reflecting various estate-planning vehicles.
What was the exercise price and term of the new HeartFlow (HTFL) stock option?
The newly granted stock option has a $27.74 per share exercise price. It covers 94,488 shares of common stock and is scheduled to expire on February 6, 2036, subject to earlier termination under the applicable equity plan and agreement terms.